Edgar Garcia-Cruz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Edgar Garcia-Cruz has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Manzur-Sandoval
Cardiovascular Critical Care Unit Instituto Nacional de Cardiología Ignacio Chávez Mexico City Mexico
2 shared publications - Julio César Sauza-Sosa
Cardiology and Echocardiography Department, The American British Cowdray Medical Center, Mexico City, Mexico
2 shared publications - Alejandra Esquivel Pineda
Centro Médico ABC
1 shared publication - Alejandra Esquivel-Pineda
Medicina Interna, Centro Médico Nacional Siglo XXI Instituto Mexicano del Seguro Social (IMSS) Ciudad de México Mexico
1 shared publication - Enma Toledo-Aleman
National Institute of Cardiology Ignacio Chavez
1 shared publication - Enma Toledo-Aleman
Cardiovascular Critical Care Unit, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico
1 shared publication
Latest Publications
- Open Access
- 6 November 2023
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 23 (1) , 1-7
Acute respiratory distress syndrome in patients with COVID-19 vs. Non-COVID-19: clinical characteristics and outcomes in a tertiary care setting in Mexico City
Background: Acute Respiratory Distress Syndrome (ARDS) due tocoronavirus disease (COVID-19) infection has a unique phenotype generating a growing need to determine the existing differences that can alter existing evidence-based management strategies for ARDS. Research Question: What differences does the clinical profile of patients with ARDS due to COVID 19 and Non-COVID 19 have? Study Design and methods: We conducted a comparative, observational, retrospective study in the Intensive Care Unit (ICU)of a third-level hospital in Mexico City, from March 2020 through March 2022. Clinical, echocardiographic, and laboratory variables were compared between patients with ARDS due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and those due to other etiologies. Results: We enrolled 140 patients with a diagnosis of ARDS. The study group of COVID-19 etiology were younger males, higher body mass index, progressed to organ dysfunction, required more frequently renal replacement therapy, and higher SOFA score. There was no difference in rates of right ventricular dysfunction. Interpretation: COVID-19 ARDS exhibit much greater severity that led to higher admission and mortality rates, whilst being younger and less comorbid.
- 6 November 2023
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 23 (1) , 1-7
Open AccessAcute respiratory distress syndrome in patients with COVID-19 vs. Non-COVID-19: clinical characteristics and outcomes in a tertiary care setting in Mexico City
Background: Acute Respiratory Distress Syndrome (ARDS) due tocoronavirus disease (COVID-19) infection has a unique phenotype generating a growing need to determine the existing differences that can alter existing evidence-based management strategies for ARDS. Research Question: What differences does the clinical profile of patients with ARDS due to COVID 19 and Non-COVID 19 have? Study Design and methods: We conducted a comparative, observational, retrospective study in the Intensive Care Unit (ICU)of a third-level hospital in Mexico City, from March 2020 through March 2022. Clinical, echocardiographic, and laboratory variables were compared between patients with ARDS due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and those due to other etiologies. Results: We enrolled 140 patients with a diagnosis of ARDS. The study group of COVID-19 etiology were younger males, higher body mass index, progressed to organ dysfunction, required more frequently renal replacement therapy, and higher SOFA score. There was no difference in rates of right ventricular dysfunction. Interpretation: COVID-19 ARDS exhibit much greater severity that led to higher admission and mortality rates, whilst being younger and less comorbid.
- Open Access
- 19 June 2023
- Published by Springer Nature in Research Square
Acute Respiratory Distress Syndrome in Patients with COVID-19 vs Non-COVID-19: Clinical characteristics and outcomes in a tertiary care setting in Mexico City.
Background ARDS due to COVID-19 infection has a unique phenotype generating a growing need to determine the existing differences that can alter existing evidence-based management strategies for ARDS, particularly those related to ventilator management. Research Question: What differences does the clinical profile of patients with ARDS due to COVID 19 and Non-COVID 19 have? Study Design and Methods: We conducted a comparative, observational, retrospective study in the ICU of a third-level hospital in Mexico City, from March 2020 through March 2022. Clinical, echocardiographic, and laboratory variables were compared between patients with ARDS due to SARS-COV2 infection and those due to other etiologies. For qualitative variables, the chi-square test was used. Results We enrolled 140 patients with a diagnosis of ARDS. The study group of COVID-19 etiology were younger males, higher body mass index, progressed to organ dysfunction, required more frequently renal replacement therapy, and higher SOFA score. There was no difference in rates of right ventricular dysfunction. Interpretation: COVID-19 ARDS exhibit much greater severity that led to higher admission and mortality rates, whilst being younger and less comorbid.
- 19 June 2023
- Published by Springer Nature in Research Square
Open AccessAcute Respiratory Distress Syndrome in Patients with COVID-19 vs Non-COVID-19: Clinical characteristics and outcomes in a tertiary care setting in Mexico City.
Background ARDS due to COVID-19 infection has a unique phenotype generating a growing need to determine the existing differences that can alter existing evidence-based management strategies for ARDS, particularly those related to ventilator management. Research Question: What differences does the clinical profile of patients with ARDS due to COVID 19 and Non-COVID 19 have? Study Design and Methods: We conducted a comparative, observational, retrospective study in the ICU of a third-level hospital in Mexico City, from March 2020 through March 2022. Clinical, echocardiographic, and laboratory variables were compared between patients with ARDS due to SARS-COV2 infection and those due to other etiologies. For qualitative variables, the chi-square test was used. Results We enrolled 140 patients with a diagnosis of ARDS. The study group of COVID-19 etiology were younger males, higher body mass index, progressed to organ dysfunction, required more frequently renal replacement therapy, and higher SOFA score. There was no difference in rates of right ventricular dysfunction. Interpretation: COVID-19 ARDS exhibit much greater severity that led to higher admission and mortality rates, whilst being younger and less comorbid.